| 丹红注射液联合甘利欣治疗慢性乙型肝炎肝纤维化的临床研究 |
| |
| 引用本文： | 王迎霞,刘志远,李庆相,张运巧,郭全合,李淑风.丹红注射液联合甘利欣治疗慢性乙型肝炎肝纤维化的临床研究[J].西南国防医药,2011,21(2):157-159. |
| |
| 作者姓名： | 王迎霞 刘志远 李庆相 张运巧 郭全合 李淑风 |
| |
| 作者单位： | 1. 邢台,河北省民政总医院,河北,054000
2. 河北省邢台市人民医院 |
| |
| 摘 要： | 目的探讨丹红注射液联合甘利欣注射液治疗慢性乙型肝炎肝纤维化的临床疗效。方法选取192例慢性乙型肝炎肝纤维化患者,随机分为治疗组110例,对照组82例,治疗组用丹红注射液联合甘利欣注射液治疗,对照组单用甘利欣注射液。观察疗程结束前后患者血清透明质酸（HA）、血清Ⅲ型前胶原（PC-Ⅲ）、层粘蛋白（LN）、Ⅳ型胶原（Ⅳ-C）、肝功能指标变化及临床疗效。结果治疗组血清肝纤维化指标、肝功能指标下降明显,而白蛋白有明显升高,与对照组相比有显著性差异（P〈0.05或P〈0.01）。结论丹红注射液联合甘利欣注射液治疗慢性乙型肝炎,可有效减轻和延缓肝纤维化的发生与发展,对肝纤维化指标和肝功能有明显改善作用。
|
| 关 键 词： | 丹红注射液 甘利欣注射液 慢性乙型肝炎 肝纤维化 肝功能 |
Clinical research on treatment of liver fibrosis in patients with chronic hepatitis B by Danhong Injection combined with Ganlixin Injection |
| |
| Wang Yingxia,Liu Zhiyuan,Li Qingxiang,Zhang Yunqiao,Guo Quanhe,Li Shufeng.Clinical research on treatment of liver fibrosis in patients with chronic hepatitis B by Danhong Injection combined with Ganlixin Injection[J].Medical Journal of National Defending forces in Southwest China,2011,21(2):157-159. |
| |
| Authors: | Wang Yingxia Liu Zhiyuan Li Qingxiang Zhang Yunqiao Guo Quanhe Li Shufeng |
| |
| Institution: | Wang Yingxia1,Liu Zhiyuan1,Li Qingxiang1,Zhang Yunqiao1,Guo Quanhe1,Li Shufeng2 1.Civil Affairs General Hospital of Hebei Province,Xingtai,Hebei,054000,China,2.People's Hospital of Xingtai City |
| |
| Abstract: | Objective To investigate the clinical efficacy of Danhong Injection combined with Ganlixin Injection on liver fibrosis in patients with chronic hepatitis B.Methods 192 cases of liver fibrosis in chronic hepatitis B were randomly divided into treatment group(n=192)and control group(n=82).Patients in treatment group were given Danhong Injection combined with Ganlixin Injection while those in the control group were only treated with Ganlixin Injection.The changes of serum hyaluronic acid(HA),serum procollagen ... |
| |
| Keywords: | Danhong Injection Ganlixin Injection chronic hepatitis B liver fibrosis liver function |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
